ARKK · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is ARK Innovation ETF (ARKK) stock moving?
ARKK fell from a late-October high near $86.71 (Oct 28) to $78.96 on Nov 2 and then to $73.15 on Nov 5, the lowest close in the 30-day window, on the largest volume of the period (13.9M versus a typical 3M to 7M). It rebounded to $77.10 by Nov 10, recovering about 5.4% from the Nov 5 close but still well below late-October levels. The news flow is mostly about the fund's holdings and Ark's trading rather than a direct fund-level catalyst: Ark bought $47.4M of SpaceX on Nov 5 while trimming Alphabet, extended Joby Aviation buying to four sessions by Oct 30, and added Cerebras after a short report. The Nov 5 article also flags political risk for Elon Musk's businesses after the midterms. Tempus AI's earnings were due the week of Nov 1, but the results are not in the provided data, so that catalyst remains unresolved. The price action points to a pullback with a short-term rebound, and the ETF's direction over the next weeks depends on holdings' news that is not yet in the data.
News behind the analysis
- Cathie Wood Buys $47.4 Million of SpaceX as Democratic Congress Looms Over Elon Musk’s Businesses After MidtermsArk added 348,406 SpaceX shares across three funds and trimmed Alphabet for a second straight session.
- Tempus AI Earnings Ahead: Is TEM Set Up To Pop or Drop?Tempus AI, a company Cathie Wood has invested in, was set to report financial results the week of Nov 1 amid continued volatility. The input does not include the results.
- Cathie Wood Isn’t Done: Ark Adds Joby Aviation For 4th Day, Buys Cerebras Stock After Short ReportArk Invest extended its Joby Aviation buying to a fourth straight session and added Cerebras shares after a short report.
About ARK Innovation ETF
ARK Innovation ETF is ARK Invest's flagship actively managed fund, run by Cathie Wood's team. It holds a concentrated portfolio of roughly 45–50 high-growth companies that ARK sees as leaders in 'disruptive innovation', and it publishes its holdings every day.
How the fund works
It doesn't track an index. ARK's managers pick the stocks, mostly US-listed innovation names, and trade them actively. As of late October 2026, the largest holdings were Tesla (about 10–11%), SpaceX (about 6%), Tempus AI, Circle, CRISPR Therapeutics, Coinbase, a private stake in OpenAI, Twist Bioscience, Shopify and Nvidia. The expense ratio is approximately 0.75% a year. The main risks: the portfolio is concentrated, it leans heavily on unprofitable or speculative companies, it holds some private or less liquid positions, and its price swings far more than broad-market funds.
What usually moves ARKK
- Interest-rate expectations and appetite for risky growth stocks
- Big moves in top holdings like Tesla and SpaceX
- Crypto prices (Coinbase, Circle, Robinhood)
- Biotech and gene-editing news
- Investors moving money in or out of the fund